Tilia Fiduciary Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-390
Closed -$6K 512
2022
Q2
$6K Hold
390
0.01% 417
2022
Q1
$8K Buy
+390
New +$8.1K 0.01% 412

Other funds holding BMEZ

Tilia Fiduciary Partners's BMEZ Position: Q3 2022 in Review

Tilia Fiduciary Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2022, closing a stake of 390 shares — an estimated $6K sold.

Tilia Fiduciary Partners first reported a position in BMEZ in Q1 2022 and held it in 2 quarters. The position peaked at $8K in Q1 2022. 75 funds tracked by Wall St. Rank hold BMEZ as of Q3 2022.

  • Tilia Fiduciary Partners reported no remaining BlackRock Health Sciences Trust II position as of Q3 2022 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 390 BlackRock Health Sciences Trust II shares in Q3 2022, an estimated $6K.
  • Tilia Fiduciary Partners first reported a position in BlackRock Health Sciences Trust II in Q1 2022 and held it in 2 quarters.
  • Tilia Fiduciary Partners's BlackRock Health Sciences Trust II position peaked at $8K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2022.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2022, filed 27 Oct 2022.